Infection Control Companies

The infection control market is estimated to grow from USD 57.31 billion in 2025 to USD 77.67 billion by 2030 at a CAGR of 6.3%.

The infection control market is experiencing significant growth driven by several key factors. The rising prevalence of healthcare-associated infections (HAIs) and the increasing number of surgical procedures underscore the critical need for effective infection prevention strategies. Advancements in reprocessing technologies enhance the efficiency and safety of sterilization processes, while the growing emphasis on sterilizing and disinfecting food products addresses public health concerns. Innovations in sterilization equipment technology further improve outcomes by offering more reliable and advanced solutions. Additionally, the growing trend of outsourcing services among pharmaceutical companies, medical device manufacturers, and hospitals reflects a strategic shift towards specialized infection control expertise, collectively fueling market expansion.

Major companies in this market include STERIS (US), Reckitt Benckiser Group plc. (UK), Fortive (US), Sotera Health (US), and Solventum (US). These companies focus on increasing sales, launching new products, and obtaining product approvals. These organic and inorganic strategies have allowed the market players to expand across geographies by offering infection control products.

To know about the assumptions considered for the study download the pdf brochure

In April 2024, Solventum completed its spinoff from 3M and began trading independently on the New York Stock Exchange under the ticker symbol “SOLV.” The company advances healthcare solutions by integrating material and data science to improve patient outcomes and support healthcare professionals.

In August 2023, STERIS acquired the surgical instrumentation, laparoscopic instrumentation, and sterilization container assets from Becton, Dickinson and Company to strengthen, complement, and expand the product portfolio within its healthcare division.

STERIS (US)

STERIS is a global leader in the infection control market, offering a comprehensive portfolio of products and services designed to prevent and manage the spread of infections across healthcare and life science settings. The company’s solutions span sterilization and decontamination equipment, including steam and low-temperature sterilizers, washer-disinfectors, and automated endoscope reprocessors, as well as cleaning and disinfecting chemicals, surgical support products, and sterile processing consumables. STERIS also provides contract sterilization services. Through continuous innovation and strategic acquisitions, STERIS has expanded its global presence and strengthened its position as a trusted partner for hospitals, pharmaceutical manufacturers, and research institutions seeking reliable infection prevention solutions.

Reckitt Benckiser Group plc. (UK)

Reckitt Benckiser is a major global player in the hygiene and infection control market, well known for its brands such as Dettol, Lysol, and others. The company’s offerings include a wide range of disinfectants and antiseptics, hand hygiene products, surface cleaners, sanitizers, and germ-protection solutions for both consumer and professional settings. During public health crises, such as the COVID-19 pandemic, Reckitt has stepped up production, supply, and donations of disinfectant and sanitization products to help reduce the spread of infection. Its corporate strategy includes focusing on “core” hygiene & health products, innovation in germ-protection formulations, and expanding business-to-business (B2B) channels (such as distributing Lysol/Dettol solutions for institutions) to reinforce its infection control presence.

Market Ranking

The infection control market is dominated by the top five players, such as STERIS (US), Reckitt Benckiser Group plc. (UK), Fortive (US), Sotera Health (US), and Solventum (US), which stand out in the market through their infection control solutions and strong R&D strength, enabling them to provide efficient infection control products. STERIS (US) gains its market position through strategic partnerships. Reckitt Benckiser Group plc. (UK) has strengthened its position with its worldwide reach. Sotera Health (US) has expanded its market presence by increasing its facility footprint in the US. The acquisition of Advanced Sterilization Products (ASP) by Fortive (US) and the spin-off of 3M’s healthcare division into Solventum (US) have significantly reshaped and boosted both companies’ positions in the infection control market.

Fortive’s acquisition of ASP, a leader in sterilization and disinfection technologies, has expanded its portfolio of infection prevention solutions, strengthened its foothold in hospital reprocessing and sterilization segments, and enhanced its global market reach through ASP’s well-established customer base. Similarly, the spin-off of 3M’s healthcare business into Solventum has enabled the new company to sharpen its strategic focus, drive operational agility, and pursue targeted growth opportunities within infection prevention and control. By operating as an independent entity, Solventum can prioritize innovation, market expansion, and brand development without the structural constraints of 3M. These strategic moves have allowed the companies to enhance competitiveness, broaden their infection control portfolios, and accelerate growth in a rapidly evolving global market.

Related Reports:

Infection Control Market by Product (Sterilization Equipment: Hydrogen Peroxide, Ethylene, Radiation), Service (ETO, Gamma, E-Beam), Disinfection (Wipes, Disinfector), Gown, Mask, Endoscope Reprocessing, End User (Hospital, Pharma) - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com